DTNBP1 genotype influences cognitive decline in schizophrenia - PubMed (original) (raw)
DTNBP1 genotype influences cognitive decline in schizophrenia
Katherine E Burdick et al. Schizophr Res. 2007 Jan.
Abstract
Objective: Intellectual decline is common in schizophrenia and predicts functional outcome. While many patients undergo intellectual decline that typically predates the onset of symptoms, few studies have investigated the underlying mechanism through which this occurs. The current study assessed the relationship between intellectual decline in schizophrenia and genetic variation in dysbindin-1 (DTNBP1).
Methods: We assessed cognitive decline in 183 Caucasian patients with schizophrenia using a proxy measure of premorbid IQ with which current general cognitive ability (g) was compared. We then tested for a relationship between the risk haplotype identified in previous work (CTCTAC) and intellectual decline.
Results: We found that carriers of the CTCTAC haplotype, demonstrated a significantly greater decline in IQ as compared with non-carriers (p=0.05).
Conclusions: These data suggest that DTNBP1 influences the severity of intellectual decline in schizophrenia and may represent one underlying cause for heterogeneity in cognitive course.
Figures
Figure 1. Intellectual Decline in Patients with Schizophrenia by DTNBP1 Genotype
Carriers of the CTCTAC risk haplotype demonstrate a greater intellectual decline than non-carriers. The data represent residual scores (observed minus predicted IQ) and are presented on the y-axis as Standard Scores (with a mean of 100 and a standard deviation of 15). The x-axis illustrates change from predicted IQ to current IQ in carriers versus non-carriers.
Similar articles
- Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects.
Hashimoto R, Noguchi H, Hori H, Ohi K, Yasuda Y, Takeda M, Kunugi H. Hashimoto R, et al. Psychiatry Clin Neurosci. 2009 Aug;63(4):550-6. doi: 10.1111/j.1440-1819.2009.01985.x. Epub 2009 May 22. Psychiatry Clin Neurosci. 2009. PMID: 19496996 - Genetic variation in DTNBP1 influences general cognitive ability.
Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, Kucherlapati R, Malhotra AK. Burdick KE, et al. Hum Mol Genet. 2006 May 15;15(10):1563-8. doi: 10.1093/hmg/ddi481. Epub 2006 Jan 13. Hum Mol Genet. 2006. PMID: 16415041 - Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis.
Varela-Gomez N, Mata I, Perez-Iglesias R, Rodriguez-Sanchez JM, Ayesa R, Fatjo-Vilas M, Crespo-Facorro B. Varela-Gomez N, et al. Cogn Neuropsychiatry. 2015;20(2):144-56. doi: 10.1080/13546805.2014.991780. Epub 2014 Dec 20. Cogn Neuropsychiatry. 2015. PMID: 25530342 - [Psychosis, bipolar disorders and cognition].
Vidailhet P. Vidailhet P. Encephale. 2009 Oct;35 Suppl 5:S164-7. doi: 10.1016/S0013-7006(09)72522-9. Encephale. 2009. PMID: 19909839 Review. French. No abstract available. - Genetics of clinical features and subtypes of schizophrenia: a review of the recent literature.
Fanous AH, Kendler KS. Fanous AH, et al. Curr Psychiatry Rep. 2008 Apr;10(2):164-70. doi: 10.1007/s11920-008-0028-z. Curr Psychiatry Rep. 2008. PMID: 18474210 Review.
Cited by
- RGS4 polymorphisms associated with variability of cognitive performance in a family-based schizophrenia sample.
Prasad KM, Almasy L, Gur RC, Gur RE, Pogue-Geile M, Chowdari KV, Talkowski ME, Nimgaonkar VL. Prasad KM, et al. Schizophr Bull. 2010 Sep;36(5):983-90. doi: 10.1093/schbul/sbp002. Epub 2009 Mar 12. Schizophr Bull. 2010. PMID: 19282471 Free PMC article. - The impact of dystrobrevin-binding protein 1 (DTNBP1) on neural correlates of episodic memory encoding and retrieval.
Thimm M, Krug A, Markov V, Krach S, Jansen A, Zerres K, Eggermann T, Stöcker T, Shah NJ, Nöthen MM, Rietschel M, Kircher T. Thimm M, et al. Hum Brain Mapp. 2010 Feb;31(2):203-9. doi: 10.1002/hbm.20857. Hum Brain Mapp. 2010. PMID: 19621369 Free PMC article. - Impact of schizophrenia-risk gene dysbindin 1 on brain activation in bilateral middle frontal gyrus during a working memory task in healthy individuals.
Markov V, Krug A, Krach S, Jansen A, Eggermann T, Zerres K, Stöcker T, Shah NJ, Nöthen MM, Treutlein J, Rietschel M, Kircher T. Markov V, et al. Hum Brain Mapp. 2010 Feb;31(2):266-75. doi: 10.1002/hbm.20862. Hum Brain Mapp. 2010. PMID: 19650139 Free PMC article. - Meta-analysis of genetic variation in DTNBP1 and general cognitive ability.
Zhang JP, Burdick KE, Lencz T, Malhotra AK. Zhang JP, et al. Biol Psychiatry. 2010 Dec 15;68(12):1126-33. doi: 10.1016/j.biopsych.2010.09.016. Biol Psychiatry. 2010. PMID: 21130223 Free PMC article. - Realising stratified psychiatry using multidimensional signatures and trajectories.
Joyce DW, Kehagia AA, Tracy DK, Proctor J, Shergill SS. Joyce DW, et al. J Transl Med. 2017 Jan 18;15(1):15. doi: 10.1186/s12967-016-1116-1. J Transl Med. 2017. PMID: 28100276 Free PMC article.
References
- Bilder RM, Reiter G, Bates J, Lencz T, Szeszko P, Goldman RS, Robinson D, Lieberman JA, Kane JM. Cognitive development in schizophrenia: follow-back from the first episode. J Clin Exp Neuropsychol. 2006;28(2):270–282. - PubMed
- Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, Kucherlapati R, Malhotra AK. Genetic Variation in DTNBP1 Influences General Cognitive Ability. Hum Mol Genet. 2006a;15(10):1563–1568. - PubMed
- Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. JNMD. 2006b;194(4):255–260. - PubMed
- Fuller R, Nopoulos P, Arndt S, O’Leary D, Ho BC, Andreasen NC. Longitudinal assessment of premorbid cognitive functioning in patients with schizophrenia through examination of standardized scholastic test performance. Am J Psychiatry. 2002;159(7):1183–1189. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical